Breast sentinel lymph node navigation with three-dimensional interstitial multidetector-row computed tomographic lymphography

Investigative Radiology

Volumn 40, Issue 6, 2005, Pages 336-342

  Suga, Kazuyoshi ^a   Yamamoto, Shigeru ^a   Tangoku, Akira ^a   Oka, Masaaki ^a   Kawakami, Yasuhiko ^a   Matsunaga, Naofumi ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Breast cancer; Computed tomography; Contrast agent; Lymphography; Sentinel lymph node

Indexed keywords

CONTRAST MEDIUM; IOPAMIDOL;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; BREAST SURGERY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; FEMALE; HUMAN; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MINIMALLY INVASIVE SURGERY; MULTIDETECTOR COMPUTED TOMOGRAPHY; PRIORITY JOURNAL; SENTINEL LYMPH NODE; THREE DIMENSIONAL IMAGING; TREATMENT PLANNING; TUMOR VOLUME;

EID: 19544381356     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rli.0000164153.41638.32     Document Type: Article

References (48)

1. Kuehn T, Bembenek A, Decker T, et al. A concept for the clinical implementation of sentinel lymph node biopsy in patients with breast carcinoma with special regard to quality assurance. Cancer 2005;103: 451-461.
2. Naik AM, Fey J, Gemignani M, et al. The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a follow-up study of 4008 procedures. Ann Surg. 2004;240:462-468.
3. Veronesi U, Paganelli G, Galimberti V, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet. 1997;349:1864-1867.
4. Veronesi U, Paganelli G, Viale G, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med. 2003;349:546-553.
5. Schwartz GF, Giuliano AE, Veronesi U. Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast April 19 to 22, 2001, Philadelphia, Pennsylvania. Cancer. 2002; 94:2542-2551.
6. Newman LA. Lymphatic mapping and sentinel lymph node biopsy in breast cancer patients: a comprehensive review of variations in performance and technique. J Am Coll Surg. 2004;199:804-816.
7. Gray RJ, Pockaj BA. A concordance study of subareolar and subdermal injections for breast cancer sentinel node mapping. Am J Surg. 2004; 188:423-425.
8. Cox CE, Pendas S, Cox JM, et al. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg. 1998;227:645-653.
9. Mariani G, Moresco L, Viale G, et al. Radioguided sentinel lymph node biopsy in breast cancer surgery. J Nucl Med. 2001;42:1198-1215.
10. Giuliano AE, Jones RC, Brennan M, et al. Sentinel lymphadenectomy in breast cancer. J Clin Oncol. 1997;15:2345-2350.
11. Viale G, Bosari S, Mazzarol G, et al. Intraoperative examination of axillary sentinel lymph nodes in breast carcinoma patients. Cancer. 1999;85:2433-2438.
12. Morrow M, Rademaker AW, Bethke KP, et al. Learning sentinel node biopsy: results of a prospective randomized trial of two techniques. Surgery. 1999;126:714-722.
13. Albertini JJ, Lyman GH, Cox C, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA. 1996;276:1818-1822.
14. Mc Masters KM, Turtle TM, Carlson DJ, et al. Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. J Clin Oncol. 2000;18:2560-2566.
15. Borgstein PJ, Pijpers R, Comans EF, et al. Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg 1998;186:275-283.
16. Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer. A multicenter validation study. N Engl J Med. 1998;339:941-946.
17. Kelly MC, Hansen N, McMasters KM. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Am J Surg. 2004;188:49-61.
18. Hansen NM. Blue versus hot: learning the techniques with dye and isotopes. Annal Surg Oncol. 2001;8:64-66.
19. Feldman SM, Krag DN, McNally RK, et al. Limitation in gamma probe localization of the sentinel node in breast cancer patients with large excisional biopsy. J Am Coll Surg. 1999;188:248-254.
20. Suga K, Ogasawara N, Okada M, et al. Interstitial CT lymphography-guided localization of breast sentinel lymph node: Preliminary results. Surgery. 2003;133:170-179.
21. Suga K, Ogasawara N, Yuan Y, et al. Visualization of breast lymphatic pathways with an indirect CT lymphography using a nonionic monometric contrast medium iopamidol: preliminary results. Invest Radiol. 2003;38:73-84.
22. Suga K, Yuan Y, Okada M, et al. Breast sentinel lymph node mapping at CT lymphography with iopamidol. Preliminary experience. Radiology. 2003;230:543-552.
23. Tangoku A, Yamamoto S, Suga K, et al. Sentinel lymph node biopsy using computed tomography-lymphography in patients with breast cancer. Surgery. 2004;135:258-265.
24. Fukui Y, Yamakawa T, Taniki T, et al. Sentinel lymph node biopsy in patients with papillary thyroid carcinoma. Cancer. 2001;92:2868-2874.
25. Fabry HFJ, Mutsaers PGNL, Meijer S, et al. Relevance of parasternal uptake in sentinel node procedure for breast cancer. J Surg Oncol. 2004;87:13-18.
26. Linehan DC, Hill ADK, Akhurst T, et al. Intradermal radiocolloid and intraparenchymal blue dye injection optimize sentinel node identification in breast cancer patients. Ann Surg Oncol. 1999;6:450-454.
27. Veronesi U, Marubini E, Mariani L, et al. The dissection of internal mammary nodes does not improve the survival of breast cancer patients. 30-year results of a randomized trial. Eur J Cancer. 1999;35:1320-1325.
28. Minato M, Hirose C, Sasa M, et al. 3-dimensional computed tomography lymphography-guided identification of sentinel lymph nodes in breast cancer patients using subcutaneous injection of nonionic contrast medium: a clinical trial. J Comput Assist Tomogr. 2004;28:46-51.
29. Casley-Smith J. The structure and functioning of the blood vessels, interstitial tissues and lymphatics. In: Foeldi M, Casley-Smith J, eds. Lymphangiology. Stuttgart. Germany: Schayyauer Verlag; 1983:27-143.
30. Lubach D, Ludemann W, Berens V, et al. Recent findings on the angioarchitecture of the lymph vessel system of human skin. Br J Dermatol. 1996;135:733-737.
31. Schmid-Schonbein GW. Microlymphatics and lymph flow. Physiol Rev. 1990;70:987-1028.
32. Suga K, Yuan Y, Ueda K, et al. Computed tomography lymphography with intrapulmonary injection of iopamidol for sentinel lymph node localization. Invest Radiol. 2004;39:313-324.
33. Sato K, Tamaki K, Takeuchi H, et al. Management of the axilla in breast cancer: a comparative study between sentinel lymph node biopsy and four-node sampling procedure. Jpn J Clin Oncol. 2001;31:318-321.
34. Mansel RE, Goyal A, Newcombe RG. Internal mammary node drainage and its role in sentinel lymph node biopsy: The initial ALMANAC experience. Clin Breast Cancer. 2004;5:279-284.
35. Farrus B, Vidal-Sicart S, Velasco M, et al. Incidence of internal mammary node metastases after a sentinel lymph node technique in breast cancer and its implication in the radiotherapy plan. Int J Radiat Oncology Phys. 2004;60:715-721.
36. Murakami G, Taniguchi I. Histologic heterogeneity and intranodal shunt flow in lymph nodes from elderly subjects: a cadaveric study. Ann Surg Oncol. 2004;11:2798-2848.
37. Kiricuta IC. The third International Symposium on target volume definition in radiation oncology based on the sentinel node procedure. In: Kiricuta IC, ed. Proceeding, 2003, Limburg, Germany. Koblenz, Germany: Druckerei & Verlag; 2003:161-171.
38. Veltman J, Boetes C, Wobbes T. Magnetic resonance-guided biopsies and localizations of the breast: initial experiences using an open breast coil and compatible intervention device. Invest Radiol. 2005;40:379-384.
39. Siegmann KC, Gorriz C, Xydeas T, et al. Preoperative magnetic resonance imaging-guided localization of 131 breast lesions with modified embolization coils. Invest Radiol. 2005;40:368-377.
40. Wisner ER, Katzberg RW, Griffey SM, et al. Characterization of normal and cancerous lymph nodes on indirect computed tomography lymphographic studies after interstitial injection of iodinated nanoparticles. Acad Radiol. 1996;3:S257-S260.
41. Wolf GL, Rogowska J, Hanna GK, et al. Percutaneous CT lymphography with perflubron: imaging efficacy in rabbits and monkeys. Radiology 1994;191:501-505.
42. Wisner ER, Weichert JP, Longino MA, et al. A surface-modified chylomicron remnant-like emulsion for percutaneous computed tomography lymphography: synthesis and preliminary imaging findings. Invest Radiol. 2002;37:232-9.
43. Wisner ER, Theon A, Griffey SM, et al. Long-term effect of irradiation on lymph node uptake of interstitially delivered nanoparticulate contrast media. Invest Radiol. 2000;35:199-204.
44. Suga K, Yuan Y, Ogasawara N, et al. Localization of breast sentinel lymph nodes by MR lymphography with a conventional gadolinium contrast agent: preliminary observations in dogs and humans. Acta Radiol. 2003;44:35-42.
45. Misselwitz B, Schmitt-Willich H, Michaelis M, et al. Interstitial magnetic resonance lymphography using a polymeric t1 contrast agent: initial experience with Gadomer-17. Invest Radiol. 2002;37:146-151.
46. Suga K, Yuan Y, Ogasawara N, et al. Visualization of normal and interrupted lymphatic drainage in dog legs with interstitial MR lymphography using an extracellular MR contrast agent, gadopentetate dimeglumine. Invest Radiol. 2003;38:349-357.
47. Fink C, Bock M, Kiessling F, et al. Interstitial magnetic resonance lymphography with gadobutrol in rats: evaluation of contrast kinetics. Invest Radiol. 2002;37:655-662.
48. Wisner ER, Ferrara KW, Short RE, et al. Sentinel node detection using contrast-enhanced power Doppler ultrasound lymphography. Invest Radiol. 2003;38:358-365.